INMED PHARMACEUTICALS (Germany) Market Value
| MWG0 Stock | 4.14 0.75 15.34% |
| Symbol | INMED |
Please note, there is a significant difference between INMED PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if INMED PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INMED PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
INMED PHARMACEUTICALS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to INMED PHARMACEUTICALS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of INMED PHARMACEUTICALS.
| 12/30/2023 |
| 12/24/2024 |
If you would invest 0.00 in INMED PHARMACEUTICALS on December 30, 2023 and sell it all today you would earn a total of 0.00 from holding INMED PHARMACEUTICALS INC or generate 0.0% return on investment in INMED PHARMACEUTICALS over 360 days. INMED PHARMACEUTICALS is related to or competes with Apple, Apple, Apple, Apple, Apple, Apple, and Microsoft. More
INMED PHARMACEUTICALS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure INMED PHARMACEUTICALS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess INMED PHARMACEUTICALS INC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.38 | |||
| Information Ratio | 0.024 | |||
| Maximum Drawdown | 69.62 | |||
| Value At Risk | (11.29) | |||
| Potential Upside | 15.31 |
INMED PHARMACEUTICALS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for INMED PHARMACEUTICALS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as INMED PHARMACEUTICALS's standard deviation. In reality, there are many statistical measures that can use INMED PHARMACEUTICALS historical prices to predict the future INMED PHARMACEUTICALS's volatility.| Risk Adjusted Performance | 0.0309 | |||
| Jensen Alpha | 0.3086 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0322 | |||
| Treynor Ratio | (0.13) |
INMED PHARMACEUTICALS INC Backtested Returns
INMED PHARMACEUTICALS appears to be dangerous, given 3 months investment horizon. INMED PHARMACEUTICALS INC holds Efficiency (Sharpe) Ratio of 0.0595, which attests that the entity had a 0.0595% return per unit of volatility over the last 3 months. By analyzing INMED PHARMACEUTICALS's technical indicators, you can evaluate if the expected return of 0.6% is justified by implied risk. Please utilize INMED PHARMACEUTICALS's risk adjusted performance of 0.0309, and Market Risk Adjusted Performance of (0.12) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, INMED PHARMACEUTICALS holds a performance score of 4. The company retains a Market Volatility (i.e., Beta) of -2.06, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning INMED PHARMACEUTICALS are expected to decrease by larger amounts. On the other hand, during market turmoil, INMED PHARMACEUTICALS is expected to outperform it. Please check INMED PHARMACEUTICALS's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether INMED PHARMACEUTICALS's current trending patterns will revert.
Auto-correlation | 0.10 |
Insignificant predictability
INMED PHARMACEUTICALS INC has insignificant predictability. Overlapping area represents the amount of predictability between INMED PHARMACEUTICALS time series from 30th of December 2023 to 27th of June 2024 and 27th of June 2024 to 24th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of INMED PHARMACEUTICALS INC price movement. The serial correlation of 0.1 indicates that less than 10.0% of current INMED PHARMACEUTICALS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 1.31 |
INMED PHARMACEUTICALS INC lagged returns against current returns
Autocorrelation, which is INMED PHARMACEUTICALS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting INMED PHARMACEUTICALS's stock expected returns. We can calculate the autocorrelation of INMED PHARMACEUTICALS returns to help us make a trade decision. For example, suppose you find that INMED PHARMACEUTICALS has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
INMED PHARMACEUTICALS regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If INMED PHARMACEUTICALS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if INMED PHARMACEUTICALS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in INMED PHARMACEUTICALS stock over time.
Current vs Lagged Prices |
| Timeline |
INMED PHARMACEUTICALS Lagged Returns
When evaluating INMED PHARMACEUTICALS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of INMED PHARMACEUTICALS stock have on its future price. INMED PHARMACEUTICALS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, INMED PHARMACEUTICALS autocorrelation shows the relationship between INMED PHARMACEUTICALS stock current value and its past values and can show if there is a momentum factor associated with investing in INMED PHARMACEUTICALS INC.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.